Assets of Fresenius Medical Care AG from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: EUR
Summary
Fresenius Medical Care AG quarterly Assets in EUR history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Fresenius Medical Care AG Assets for the quarter ending 31 Dec 2024 was €33,566,579,000, a 1.1% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (EUR)
Assets, YoY Quarterly Change (%)

Fresenius Medical Care AG Quarterly Assets (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 €33,566,579,000 -€363,229,000 -1.1% 31 Dec 2024 20-F 25 Feb 2025 2024 FY
Q3 2024 €32,510,801,000 -€3,123,895,000 -8.8% 30 Sep 2024 6-K 05 Nov 2024 2024 Q3
Q2 2024 €33,896,204,000 -€1,063,934,000 -3% 30 Jun 2024 6-K 30 Jul 2024 2024 Q2
Q1 2024 €34,336,099,000 -€1,164,416,000 -3.3% 31 Mar 2024 6-K 07 May 2024 2024 Q1
Q4 2023 €33,929,808,000 -€1,824,306,000 -5.1% 31 Dec 2023 20-F 25 Feb 2025 2024 FY
Q3 2023 €35,634,696,000 -€2,771,739,000 -7.2% 30 Sep 2023 6-K 05 Nov 2024 2024 Q3
Q2 2023 €34,960,138,000 -€1,109,588,000 -3.1% 30 Jun 2023 6-K 30 Jul 2024 2024 Q2
Q1 2023 €35,500,515,000 +€776,389,000 +2.2% 31 Mar 2023 6-K 07 May 2024 2024 Q1
Q4 2022 €35,754,114,000 +€1,387,556,000 +4% 31 Dec 2022 20-F 25 Feb 2025 2024 FY
Q3 2022 €38,406,435,000 +€4,575,509,000 +14% 30 Sep 2022 6-K 02 Nov 2023 2023 Q3
Q2 2022 €36,069,726,000 +€3,082,519,000 +9.3% 30 Jun 2022 6-K 02 Aug 2023 2023 Q2
Q1 2022 €34,724,126,000 +€1,565,587,000 +4.7% 31 Mar 2022 6-K 09 May 2023 2023 Q1
Q4 2021 €34,366,558,000 +€2,677,522,000 +8.4% 31 Dec 2021 20-F 20 Feb 2024 2023 FY
Q3 2021 €33,830,926,000 +€781,791,000 +2.4% 30 Sep 2021 6-K 31 Oct 2022 2022 Q3
Q2 2021 €32,987,207,000 -€1,202,646,000 -3.5% 30 Jun 2021 6-K 02 Aug 2022 2022 Q2
Q1 2021 €33,158,539,000 -€913,888,000 -2.7% 31 Mar 2021 6-K 04 May 2022 2022 Q1
Q4 2020 €31,689,036,000 -€1,245,699,000 -3.8% 31 Dec 2020 20-F 22 Feb 2023 2022 FY
Q3 2020 €33,049,135,000 -€120,268,000 -0.36% 30 Sep 2020 6-K 02 Nov 2021 2021 Q3
Q2 2020 €34,189,853,000 +€2,233,852,000 +7% 30 Jun 2020 6-K 30 Jul 2021 2021 Q2
Q1 2020 €34,072,427,000 +€1,719,223,000 +5.3% 31 Mar 2020 6-K 06 May 2021 2021 Q1
Q4 2019 €32,934,735,000 +€6,692,467,000 +26% 31 Dec 2019 20-F 22 Feb 2022 2021 FY
Q3 2019 €33,169,403,000 +€7,582,317,000 +30% 30 Sep 2019 6-K 29 Oct 2020 2020 Q3
Q2 2019 €31,956,001,000 +€6,911,073,000 +28% 30 Jun 2019 6-K 30 Jul 2020 2020 Q2
Q1 2019 €32,353,204,000 +€8,196,143,000 +34% 31 Mar 2019 6-K 06 May 2020 2020 Q1
Q4 2018 €26,242,268,000 +€2,217,053,000 +9.2% 31 Dec 2018 20-F 23 Feb 2021 2020 FY
Q3 2018 €25,587,086,000 +€1,336,728,000 +5.5% 30 Sep 2018 6-K 31 Oct 2019 2019 Q3
Q2 2018 €25,044,928,000 +€330,015,000 +1.3% 30 Jun 2018 6-K 30 Jul 2019 2019 Q2
Q1 2018 €24,157,061,000 -€1,622,611,000 -6.3% 31 Mar 2018 6-K 02 May 2019 2019 Q1
Q4 2017 €24,025,215,000 -€1,478,424,000 -5.8% 31 Dec 2017 20-F 20 Feb 2020 2019 FY
Q3 2017 €24,250,358,000 30 Sep 2017 6-K 30 Oct 2018 2018 Q3
Q2 2017 €24,714,913,000 30 Jun 2017 6-K 01 Aug 2018 2018 Q2
Q1 2017 €25,779,672,000 31 Mar 2017 6-K 03 May 2018 2018 Q1
Q4 2016 €25,503,639,000 31 Dec 2016 20-F 20 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.